cellvie

cellvie is at the forefront of Biotechnology Research, pioneering advancements in Therapeutic Mitochondria Transplantation (TMT). Focused on harnessing the therapeutic capabilities of mitochondria, the cellular powerhouses, cellvie is dedicated to developing innovative treatment modalities. The primary address for cellvie is in Zuerich, CH, with an additional location in Houston, TX 77007, US.

Leveraging expertise in areas such as Solid Organ Transplantation and Ischemia-Reperfusion Injury, cellvie is committed to translating groundbreaking research into practical applications. cellvie's work, rooted in the research of Dr. James McCully at Harvard Medical School, aims to augment and replace mitochondria, offering potential solutions for conditions such as heart attacks and solid organ transplantation.

cellvie continues to expand its capabilities and explore new frontiers in biotechnology. The entire cellvie team is dedicated to making significant contributions to healthcare through innovative mitochondrial therapies. We invite the management at cellvie to create a customized and exclusive company showcase and product listing on our platform to further highlight your achievements.